Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cells.
Cell death & disease
View this publicationCell death & disease
View this publicationJournal of the European Academy of Dermatology and Venereology : JEADV
View this publicationMolecular metabolism
View this publicationBioinformatics (Oxford, England)
View this publicationPediatric radiology
View this publicationDie Ophthalmologie
View this publicationThe Journal of infectious diseases
View this publicationThe Biochemical journal
View this publicationJournal of cardiac failure
View this publicationFrontiers in aging neuroscience
View this publication